Pfizer Inc. Chief Executive Hank McKinnell says the companys Bextra anti-inflammatory drug will probably return to the market because of patient demand, according to Reuters. 

Last month, the Food and Drug Administration forced Manhattan-based Pfizer to suspend sales of the Cox-2 inhibitor drug because of concerns about its health risks, and said Celebrex, another Cox-2 inhibitor, should carry a black box warning the strongest possible caution.

Late last year, Pfizer put a black box warning on Bextra, citing cardiovascular risks, and the risk of a rare but fatal skin rash.

In an interview with Reuters today, following a speech at an HIV/AIDS prevention meeting in Atlanta, Mr. McKinnell said Bextra was the best choice or the only choice for some patients.

The company issued a statement, saying it plans to discuss options with the FDA under which Bextra might be made available to those patients.

We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Bextra, Celebrex MDL judge sets first Bextra trial

On the heels of the $4.85 Billion Vioxx settlement, the Multi-District Litigation (MDL) Court for the...


What is Bextra? Bextra is valdecoxib-based drug that is administered orally. Bextra is used as...

Health Canada Prohibits Sale Of Bextra In Canada

Following a review of safety information, Health Canada is informing the public that Bextra, an...

Bextra's Return Barred by Health Canada

Bextra is a member of a class of drugs known as cox-2 inhibitors. Better known cox-2s are Celebrex,...

FDA Rejects Bextra-Like Drug

The FDA has decided not to approve a special formulation of Pfizer's recalled pain reliever Bextra that...

SEC asking Pfizer for Bextra, Celebrex Data

Pfizer Inc. is responding to a request from the Securities and Exchange Commission for information and...

Thank you for all your hard work

Thank you for all your hard work over the past years on my behalf and so many others. God bless you all.